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Abstract
Until now, Belgium has been considered as a low-risk country
for alveolar echinococcosis. However it was recently demonstrated
by necropsy series that, in some parts of southern Belgium
(Wallonia), up to 51% of the red foxes (Vulpes vulpes) may be
infected by E. multilocaris. The authors, working in a university
hospital in southern Belgium, described in 2002 the first
autochthonous Belgian case of hepatic alveolar echinococcosis.
More importantly, in 2004, they diagnosed three other patients
with alveolar echinococcosis. One underwent surgical resection,
but two others had bilateral pulmonary involvement at time of def-
inite diagnosis. Palliative albendazole therapy was initiated. These
patients had been diagnosed with hepatic mass from unknown ori-
gin for several months. The previous experience with the first case
allowed the authors to consider and to confirm alveolar echinococ-
cosis diagnosis, made by pathology and/or serological tests and
imaging. These four patients with alveolar echinococcosis were liv-
ing either in the Liege or the Luxembourg province. Considering
the high prevalence of E. multilocaris infection of red foxes and the
recent increase of the fox population due to rabies vaccination in
southern Belgium, and also the presence of E. multilocaris infec-
tion of red foxes in northern Belgium, it is likely that not only
Wallonia, but also maybe the whole Belgium, may face endemic
alveolar echinococcosis in the next years. (Acta gastroenterol. belg.,
2005, 68, 1-4).
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Introduction
Alveolar echinococcosis is a life-threatening zoono-
sis caused by the larval stages of Echinococcus multilo-
caris (1). It has to be differentiated from infection by E.
granulosus that develops in human in form of hydatid
cysts. Until now, Belgium has been considered as a low-
risk country for E. multilocaris infection in humans.
However it was recently demonstrated by necropsy
series that, in some parts of southern Belgium
(Wallonia), up to 51% of the red foxes (Vulpes vulpes)
may be infected by E. multilocaris (2,3), a level that
should be considered as a high prevalence (4). The
authors, working in a university hospital in southern
Belgium, reported the first autochthonous Belgian case
of hepatic alveolar echinococcosis in this journal in
2002 (5). More importantly, in 2004, they diagnosed
three other patients with alveolar echinococcosis. The
aim of this report is to summarize these cases to better
inform the medical community on this possible diagno-
sis in Belgium. The authors also shortly review the
pathology and the treatment of this disease.
Case reports
Case 1
A 61-year old man living in the Luxembourg
province was suffering from emphysema and underwent
a thoracic computed tomography (CT). This exam
showed a 45 mm lesion in the right liver lobe, consid-
ered as a malignant secondary liver mass. Complete
exploration was undertaken, including research for the
primary lesion (gastroscopy, colonoscopy), abdominal
CT (Fig. 1), positron emission tomography. This explo-
ration was not contributive. Explorative laparoscopy
demonstrated a segment IV liver mass. Biopsies were
not conclusive and the patient was sent for partial liver
resection. Pathology of resected segments demonstrated
alveolar echinococcosis (Fig. 2 and Fig. 3). Post-
operative echinococcus serology was positive. Adjuvant
albendazole (Zentel) therapy was initiated.
Case 2
A 70-year old man living in the Liege province with
past history of chronic myeloid leukaemia was diag-
nosed with a left liver mass in 2003. Serology for filaria
and strongyloidiasis was positive and mebendazole
(Vermox, Janssen, Belgium) treatment was initiated. In
July 2004 a liver CT showed progression of the disease
with invasion of the right part of the liver. Thoracic CT
demonstrated bilateral metastases. Echinococcus serolo-
gy became positive, although it was negative in 2003.
Alveolar echinococcosis was diagnosed and palliative
albendazole therapy was initiated.
Case 3
A 76-year old man living in the Luxembourg
province had past history of chronic myelomonocytic
leukaemia. In 2002 an abdominal CT showed a large
right liver lesion. Follow-up showed slow size increase
(Fig. 4). Echinococcus serology was slightly positive in
August 2004 and alveolar echinococcosis was diag-
nosed. Albendazole therapy was initiated. In September
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2004 a thoracic CT showed several pulmonary lesions
without pleural effusion or adenopathy (Fig. 5). 
Discussion
These three patients, added to the case described in
2002 (5), were the first patients suffering from alveolar
echinococcosis encountered in the authors’ experience,
and the first patients published in Belgium to date,
despite the evocation of up to 6 Belgian contaminated
patients (6). All our patients were over 60 years of age,
and none had a particular history of journey in endemic
regions for alveolar echinococcosis. Another interesting
evidence is that three of these patients had some degree
of decreased immunity (corticosteroid therapy or chron-
ic leukaemia). In the four cases, the diagnosis of alveo-
lar echinococcosis was late, either on the hepatectomy
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Fig. 1. — Computed tomography of the liver (case 1) ; show-
ing hepatic segment IV infection by E. multilocaris.
Fig. 3. — Pathology of the resected tissue (hematoxylin-eosin,
25 ) showing a cystic formation surrounded by a laminine
ringed membrane ; protoscolices are limited by necrosis, fibro-
sis and inflammatory reaction (case 1).
Fig. 4. — Magnetic resonance imaging of the liver (case 3),
showing a large, polycystic mass of the right liver.
Fig. 5. — Computed tomography of the chest (case 3) showing
pulmonary E. multilocaris metastases.
Fig. 2. — Gross photography of the resected liver section
(case 1), showing a solid, white mass with irregular multilocu-
lar, necrotic and cystic cavities containing thick pasty materi-
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specimen, or after extra hepatic involvement contraindi-
cating radical surgical procedure. These late diagnoses
may be linked to the fact that until recently Belgium has
been considered as a low-risk country for alveolar
echinococcosis. However it was recently demonstrated
by necropsy series that, in some parts of southern
Belgium, up to 51% of the red foxes may be infected by
E. multilocaris (2,3). Considering this high prevalence
of E. multilocaris infection of red foxes and the recent
increase of fox population due to rabies vaccination in
southern Belgium, added to the first reports of human
cases, it is likely that this region will face endemic alve-
olar echinococcosis in the next years. In addition, other
necropsy studies showed that in northern Belgium, red
foxes might also be infected by E. multilocaris (6),
although at a lower rate than in southern Belgium.
Therefore, for these reasons added to the small size of
Belgium, the authors considered that cases of alveolar
echinococcosis might be diagnosed in the whole country
in the next future. 
E. multilocularis cycle
The adult E. multilocularis is a tapeworm living
attached to the small intestine of the definitive host,
mainly the red fox, but dogs and cats are also vulnerable
(1). When the gravid proglottis arrives to maturity, it is
released in the faeces with 400 to 800 eggs. The eggs
contain the oncospheres, which have six hooks sur-
rounded by protective envelopes. The cycle continues if
field rodents (intermediate carriers) ingest the eggs.
Reaching the stomach of an intermediate host, the
oncospheres are released from their protective coat, and
by means of its larval hooks, penetrate the intestinal
wall. The oncospheres migrate via the portal circulation
to the liver, where most are deposited and develop.
When the intermediate host dies and his vital organs are
devoured, each consumed scolex may transform in an
adult larva in the small intestine of the definitive host.
Human beings are accidental intermediate hosts in this
cycle, and may be contaminated mainly by eating wild
berries such as wood strawberries, blackberries, blue-
berries or many other vegetables that could be soiled
with foxes excrements, or by contacts with contaminat-
ed foxes or domestic animals (1).
Clinical features
Asymptomatic incubation may last 5 to 15 years.
Immunosuppression is believed to favour more rapid
disease progression. The peak age group for infection is
from 50 to 70 years (1). The metacestode develops
almost exclusively primarily in the liver (99% of cases).
Thirteen percent of cases present as multiorgan disease
where metacestodes involve the lungs, spleen or brain in
addition to the liver (1). Alveolar echinoccoccosis symp-
toms are due to progressive hepatic invasion. One-third
of cases present with cholestatic jaundice, one-third with
epigastric pain, and the remainder present with vague
symptoms like weight loss or fatigue, or are noted to
have incidental hepatomegaly. Untreated or inadequate-
ly managed cases have high fatality rates (1).
Diagnosis
Definite diagnosis may be made by physical imaging
methods, as ultrasonography, CT, and magnetic reso-
nance imaging (7), in addition to serology (1).
Immunodiagnosis is useful not only in primary diagno-
sis but also for follow-up of patients after surgical or
pharmacological treatment (1). Antibody detection by
Em2plus ELISA has proved especially valuable. As
there are some antigen similarities between E. granulo-
sus and multilocaris, ELISA tests for E granulosus may
be positive in alveolar echinococcosis. Percutaneous or
laparoscopic biopsies are most often non-contributive
and are not necessary for the diagnosis of E multilocaris
infection if imaging and serology are positive.
Treatment
Radical surgical resection – as for hepatic malignan-
cy – is the only curative method for alveolar echinococ-
cosis, stressing the importance of early diagnosis (1).
Perioperative and long-term adjuvant therapy with
albendazole (doses up to 20 mg/kg/day) has been asso-
ciated with improved results. Albendazole is only para-
sitostatic against E. multilocaris, and should be contin-
ued for two years after surgery (1). In palliative man-
agement, long-term albendazole therapy is advocated.
Amphotericin B was recently proposed in cases of resis-
tance to albendazole (8). The role of life-long chemo-
suppression is being explored. Liver transplantation has
been undertaken in patients with alveolar echonococco-
sis (9,10) but the immunosuppression linked to trans-
plantation may favour increased development of extra
hepatic disease.
Prevention and control
Primary prevention could be to treat all definitive
hosts, foxes and dogs, with praziquantel (Biltricide)
(11). However, this chemotherapy is difficult to apply at
a large scale. Vaccination of definite or intermediate
hosts is subject to research (1). For human, primary pre-
vention consists of avoiding eating fresh vegetables or
fruits that grow at less than 50 cm from the ground, and
avoiding contact with wild foxes and dogs. Vegetable
cooking (at least 10 min at 60°C, 5 min at 70°C, or 1 min
at 100°C), but not freezing, is efficient to inactivate the
eggs (oncospheres).
In summary, these cases demonstrated that in south-
ern Belgium, alveolar echinococcosis should be consid-
ered as a potential diagnosis of any liver mass.
Appropriate information of the Belgian medical doctors
is crucial as only early diagnosis may allow surgical
curative treatment. Considering the infection of E. mul-
tilocaris of red foxes and the recent increase of fox
population due to rabies vaccination, it is likely that
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southern Belgium, but also maybe the whole Belgium,
may face endemic alveolar echinococcosis in the next
future.
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